Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Vivian Weerdesteyn benoemd tot hoogleraar in Nijmegen
apr 2021 | Bewegingsstoornissen, Neuro-vasculair